Cargando…

Validation of the GALAD model and establishment of a new model for HCC detection in Chinese patients

BACKGROUND: GALAD model is a statistical model used to estimate the possibility of hepatocellular carcinoma (HCC) in patients with chronic liver disease. Many studies with other ethnic populations have shown that it has high sensitivity and specificity. However, whether this model can be used for Ch...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Ping, Song, Haolin, Xu, Wei, Guo, Jin, Wang, Jianfei, Zhou, Juhong, Kang, Xiang, Jin, Chaolei, Cai, Yubo, Feng, Zixuan, Gao, Hainv, Lu, Fengmin, Li, Lanjuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817025/ https://www.ncbi.nlm.nih.gov/pubmed/36620588 http://dx.doi.org/10.3389/fonc.2022.1037742

Ejemplares similares

Corrigendum: Validation of the GALAD model and establishment of a new model for HCC detection in Chinese patients
por: Chen, Ping, et al.
Publicado: (2023)

Validation of the GALAD Model and Establishment of GAAP Model for Diagnosis of Hepatocellular Carcinoma in Chinese Patients
por: Liu, Miaoxia, et al.
Publicado: (2020)

ASAP Score versus GALAD Score for detection of hepatitis C-related hepatocellular carcinoma: A multicenter case-control analysis
por: Liu, Si-Yu, et al.
Publicado: (2022)

Surveillance and treatment of primary hepatocellular carcinoma (aka. STOP HCC): protocol for a prospective cohort study of high-risk patients for HCC using GALAD-score
por: Truong, Thai Ngoc, et al.
Publicado: (2023)

GALAD outperforms aMAP and ALBI for predicting HCC in patients with compensated advanced chronic liver disease: A 12-year prospective study
por: Villa, Erica, et al.
Publicado: (2023)

Galad Score as a Prognostic Marker for Patients with Hepatocellular Carcinoma
por: Cagnin, Silvia, et al.
Publicado: (2023)

Establishment and Validation of an Integrated Model to Predict Postoperative Recurrence in Patients With Atypical Meningioma
por: Chen, Xiao-Yong, et al.
Publicado: (2021)

Cabozantinib for HCC Treatment, From Clinical Back to Experimental Models
por: Deng, Shanshan, et al.
Publicado: (2021)

Establishment and validation of exhausted CD8+ T cell feature as a prognostic model of HCC
por: Shi, Jihang, et al.
Publicado: (2023)

Establishment and validation of a clinicopathological prognosis model of gastroenteropancreatic neuroendocrine carcinomas
por: Chen, Jing, et al.
Publicado: (2022)

Establishment and validation of nomogram model for the diagnosis of AFP-negative hepatocellular carcinoma
por: Liu, Long, et al.
Publicado: (2023)

Establishment and Validation of a Novel MRI Radiomics Feature-Based Prognostic Model to Predict Distant Metastasis in Endemic Nasopharyngeal Carcinoma
por: Li, Hao-Jiang, et al.
Publicado: (2022)

Evaluation of GALAD Score in Diagnosis and Follow-up of Hepatocellular Carcinoma after Local Ablative Therapy
por: Eletreby, Rasha, et al.
Publicado: (2023)

Correlation Between Prognostic Biomarker SLC1A5 and Immune Infiltrates in Various Types of Cancers Including Hepatocellular Carcinoma
por: Zhao, Junsheng, et al.
Publicado: (2021)

US-Based Deep Learning Model for Differentiating Hepatocellular Carcinoma (HCC) From Other Malignancy in Cirrhotic Patients
por: Zhou, Hang, et al.
Publicado: (2021)

Splenic Volume, an Easy-To-Use Predictor of HCC Late Recurrence for HCC Patients After Hepatectomy
por: Fang, Tongdi, et al.
Publicado: (2022)

Establishing a novel model of malignant airway stenosis in rabbit
por: Lin, Xiaoxiao, et al.
Publicado: (2022)

Development and Validation of a Radiosensitivity Prediction Model for Lower Grade Glioma Based on Spike-and-Slab Lasso
por: Du, Zixuan, et al.
Publicado: (2021)

Potential candidates for liver resection in liver-confined advanced HCC: a Chinese multicenter observational study
por: Bai, Tingting, et al.
Publicado: (2023)

Upregulation of Serum Sphingosine (d18:1)-1-P Potentially Contributes to Distinguish HCC Including AFP-Negative HCC From Cirrhosis
por: Jiang, Yingying, et al.
Publicado: (2020)

Validating RRP12 Expression and Its Prognostic Significance in HCC Based on Data Mining and Bioinformatics Methods
por: Wei, Chao, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors in the Treatment of HCC
por: Donisi, Clelia, et al.
Publicado: (2021)

Study on the changes of CT texture parameters before and after HCC treatment in the efficacy evaluation and survival predication of patients with HCC
por: Zhou, Wei, et al.
Publicado: (2022)

Establishment and validation of novel MRI radiomic feature-based prognostic models to predict progression-free survival in locally advanced rectal cancer
por: Xie, Fei, et al.
Publicado: (2022)

GALAD Score Detects Early-Stage Hepatocellular Carcinoma in a European Cohort of Chronic Hepatitis B and C Patients
por: Schotten, Clemens, et al.
Publicado: (2021)

The Performance of GALAD Score for Diagnosing Hepatocellular Carcinoma in Patients with Chronic Liver Diseases: A Systematic Review and Meta-Analysis
por: Guan, Ming-Cheng, et al.
Publicado: (2023)

The Combination of AFP and “Up-To-Seven” Criteria May Be a Better Strategy for Liver Transplantation in Chinese Cirrhotic HCC Patients
por: Zhang, Da-li, et al.
Publicado: (2022)

A novel HCC prognosis predictor PDSS1 affects the cell cycle through the STAT3 signaling pathway in HCC
por: Rao, Zuqin, et al.
Publicado: (2022)

Prognostic value of combined inflammatory and nutritional biomarkers in HCC within the Milan criteria after hepatectomy
por: Feng, Hanxin, et al.
Publicado: (2022)

Establishment of Criteria for Molecular Differential Diagnosis of MPLC and IPM
por: Wang, Xiaohui, et al.
Publicado: (2021)

SLC1A4: A Powerful Prognostic Marker and Promising Therapeutic Target for HCC
por: Peng, Xiaozhen, et al.
Publicado: (2021)

Establishment and validation of a prognostic nomogram for extrahepatic cholangiocarcinoma
por: Zhao, Fangrui, et al.
Publicado: (2022)

Identify optimal HAP series scores for unresectable HCC patients undergoing TACE plus sorafenib: A Chinese multicenter observational study
por: Zhu, Yejing, et al.
Publicado: (2023)

Establishment and validation of a radiological-radiomics model for predicting high-grade patterns of lung adenocarcinoma less than or equal to 3 cm
por: Dong, Hao, et al.
Publicado: (2022)

Prognostic Model and Nomogram Construction Based on a Novel Ferroptosis-Related Gene Signature in Lower-Grade Glioma
por: Zhao, Junsheng, et al.
Publicado: (2021)

Kill and Clearance in HCC: An Approach Based on NK Cells and Macrophages
por: Mehrabi, Maryam, et al.
Publicado: (2021)

Epigenetic Mechanisms Involved in HCV-Induced Hepatocellular Carcinoma (HCC)
por: Zhao, Pin, et al.
Publicado: (2021)

Evaluation of D-TACE combined with endovascular brachytherapy for HCC with MPVTT
por: Huang, Wei, et al.
Publicado: (2022)

Hsa-miR-4277 Decelerates the Metabolism or Clearance of Sorafenib in HCC Cells and Enhances the Sensitivity of HCC Cells to Sorafenib by Targeting cyp3a4
por: He, Xi, et al.
Publicado: (2021)

Establishing and Maintaining an Extensive Library of Patient-Derived Xenograft Models
por: Mattar, Marissa, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_nnv30audijuqnjvodacf6matra